People with MS have persistently high levels of EBV antibodies, a study found, pointing to a way to distinguish MS from ...

Guest writer Karen Matingou promised her teenage son she would face living with MS with strength, discipline, and a warrior ...

Guest writer Josh Bell regrets not focusing on the mental and emotional side of living with MS more quickly after he was ...

Guest writer Shayna Goerdt shares the ups and downs of her journey with MS. Among the highs is advocating for the community, ...

Immunic Therapeutics was granted a patent in Europe that protects all dosing regimens of its MS therapy vidofludimus calcium ...

Briumvi significantly outperformed Aubagio at reducing disease activity in people with highly active relapsing forms of MS, a ...

A study questioned the use of brain volume loss as a clinical trial endpoint in PPMS after finding a weak link to disability ...

A Phase 1 trial testing TG Therapeutics' CAR T-cell therapy azer-cel in progressive forms of MS is now recruiting across ...

For Izzy Abbass, who grew up around mountains, climbing them, and overcoming hurdles with MS, is easier with good support.

As columnist Ahna Crum marveled at the feats of Olympic medalists, she decided to grab a pair of ice skates and test her own ...

Many MS genetic risk factors are shared across ancestral backgrounds, but European-focused studies may miss others, per a study.

A second clinical trial testing fenebrutinib for MS has met its main goal, once again beating approved Aubagio in reducing ...